Jiangxi Biotech (6915) launched its Hong Kong IPO on June 20, with subscriptions closing on June 25 and trading expected to begin on June 30. The offer price range is HK$9.33 to HK$13.06, according to Ming Pao, with board lots of 500 shares and an entry fee of HK$6,595.86.
The global offering comprises 36.2345 million shares, including 3.6235 million shares for the Hong Kong public tranche, and is expected to raise about HK$473 million. CICC and China Merchants Securities International are joint sponsors.
STOCKS | Jiangxi Biotech (6915) Starts IPO Bookbuilding, Targets June 30 Listing
2026-06-22 02:19:02
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
FedEx, Micron Earnings and May PCE Data Due This WeekNext article：
Hyperliquid上10倍CL多单浮亏133万美元
